skip to main content

H.R. 2376: Prescription Pricing for the People Act of 2019

Call or Write Congress

To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Doug Collins

Sponsor. Representative for Georgia's 9th congressional district. Republican.

Read Text »
Last Updated: Apr 29, 2019
Length: 5 pages
Introduced
Apr 29, 2019
Status

Ordered Reported on Apr 30, 2019

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on April 30, 2019.

Prognosis
2% chance of being enacted according to Skopos Labs (details)
See Instead

S. 1227 (same title)
Ordered Reported — Jun 27, 2019

Source

Position statements

What legislators are saying

House Judiciary Unanimously Passes Bipartisan Bills to Lower Prescription Drug Prices
    — Rep. Jerrold Nadler [D-NY10] (Co-sponsor) on Apr 30, 2019

Congressman Cohen Works to Lower Prescription Drug Costs
    — Rep. Steve Cohen [D-TN9] (Co-sponsor) on Apr 30, 2019

Chairman Nadler Statement for the Markup of H.R. 2376, the Prescription Pricing for the People Act of 2019
    — Rep. Jerrold Nadler [D-NY10] (Co-sponsor) on Apr 30, 2019

More statements at ProPublica Represent...

What stakeholders are saying

Institute for Spending Reform SpendingTracker.org estimates H.R. 2376 will add $2 million in new spending through 2020.

History

Apr 29, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Apr 30, 2019
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

May 21, 2019
 
Considered by Health

A committee held a hearing or business meeting about the bill.

If this bill has further action, the following steps may occur next:
 
Passed House

 
Passed Senate

 
Signed by the President

H.R. 2376 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2376 — 116th Congress: Prescription Pricing for the People Act of 2019.” www.GovTrack.us. 2019. September 20, 2019 <https://www.govtrack.us/congress/bills/116/hr2376>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.